Definium Therapeutics (DFTX) Interest & Investment Income (2020 - 2026)
Definium Therapeutics (DFTX) reported Interest & Investment Income of $3.5 million for Q1 2026, up 42.09% year-over-year from $2.4 million in Q1 2025, and down 0.97% on a QoQ basis from $3.5 million in Q4 2025.
Definium Therapeutics (DFTX) has 6 years of Interest & Investment Income data on file, last reported at $3.5 million in Q1 2026.
- Quarterly Interest & Investment Income rose 42.09% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.0 million (down 2.85% YoY) and the FY2025 annual result came in at $11.0 million, down 5.17% from the prior year.
- Interest & Investment Income retreated to $3.5 million in Q1 2026 per DFTX's latest filing, from $3.5 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.5 million in Q3 2024 and bottomed at $1.3 million in Q4 2023.
- The 4-year median for Interest & Investment Income is $2.4 million (2025), against an average of $2.4 million.
- The widest annual swing landed in 2024, when Interest & Investment Income soared 143.97%; it then plunged 35.5% in 2025.
- Tracing DFTX's Interest & Investment Income over 4 years: stood at $1.3 million in 2023, then soared by 143.97% to $3.3 million in 2024, then advanced by 6.47% to $3.5 million in 2025, then fell by 0.97% to $3.5 million in 2026.
- Per Business Quant, the three latest DFTX Interest & Investment Income figures stand at $3.5 million (Q1 2026), $3.5 million (Q4 2025), and $2.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - | 3.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.46 Mn |
| Dec 31, 2025 | 3.49 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 2.77 Mn |
| Mar 31, 2025 | 2.43 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Sep 30, 2024 | 3.51 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.39 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 22,000.00 |
| Sep 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Mar 31, 2020 | 5,000.00 |